Living without oxygen
is not possible, but apart from merely having it all around, it is also
important to have a good pair of lungs, to be able to take in the gas and
convert it to energy. Since life isn’t fair and not everything is good, there
are a horde of respiratory diseases which hamper with the functioning of the
lungs. Among the most common are chronic obstructive pulmonary disease (COPD) and
asthma, with the World Health Organization (WHO) putting their annual incidence
at 251 million and 235 million cases, respectively.
To Learn more about this report@ https://bit.ly/2MoLDEc |
On a geographical basis, the largest respiratory diagnostic and monitoring device market is currently North America, as it has a fast growing geriatric population. For instance, compared to 49.2 million in 2016, 98 million people would be in the age group of 65 and above, in the U.S., in 2060, as per government sources. Additionally, the country has been the worst struck by COVID-19, registering the highest worldwide death count of 42,518, as of April 21, 2020. Additionally, a range of new and improved devices are being launched in the continent, which would further help increase their uptake.
Read more: https://www.psmarketresearch.com/market-analysis/respiratory-diagnostic-and-monitoring-device-market